Global molecular dysfunctions in gastric cancer revealed by an integrated analysis of the phosphoproteome and transcriptome

Cellular and Molecular Life Sciences

Volumn 68, Issue 11, 2011, Pages 1983-2002

  Guo, Tiannan ^a,b   Lee, Sze Sing ^a   Ng, Wai Har ^a   Zhu, Yi ^b   Gan, Chee Sian ^b   Zhu, Jiang ^c   Wang, Haixia ^c   Huang, Shiang ^c   Sze, Siu Kwan ^b   Kon, Oi Lian ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DNA damage response; Gastric cancer; Mitochondria; Phosphoproteome; Protein antibody array; Protein kinase; Protein phosphatase; Transcriptome

Indexed keywords

CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE; PHOSPHOPROTEOME; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEOME; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CONTROLLED STUDY; DNA DAMAGE; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; STOMACH BIOPSY; STOMACH CANCER; TANDEM MASS SPECTROMETRY;

CELL LINE, TUMOR; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GENE EXPRESSION PROFILING; HUMANS; PROTEOME; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 79958199896     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-010-0545-x     Document Type: Article

References (66)

1. RM Peek Jr MJ Blaser 2002 Helicobacter pylori and gastrointestinal tract adenocarcinomas Nat Rev Cancer 2 28 37 11902583 10.1038/nrc703 1:CAS:528:DC%2BD38XhvF2jt7c%3D (Pubitemid 37328805)
2. AD Wagner M Moehler 2009 Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era Curr Opin Oncol 21 381 385 19412098 10.1097/CCO.0b013e32832c42e0 1:CAS:528:DC%2BD1MXnsVehsrc%3D
3. C Sawyers 2004 Targeted cancer therapy Nature 432 294 297 15549090 10.1038/nature03095 1:CAS:528:DC%2BD2cXpvVCjtL8%3D (Pubitemid 39551656)
4. S Di Cosimo J Baselga 2010 Management of breast cancer with targeted agents: importance of heterogeneity. [corrected] Nat Rev Clin Oncol 7 139 147 20125090 10.1038/nrclinonc.2009.234
5. FJ Esteva D Yu MC Hung GN Hortobagyi 2010 Molecular predictors of response to trastuzumab and lapatinib in breast cancer Nat Rev Clin Oncol 7 98 107 20027191 10.1038/nrclinonc.2009.216 1:CAS:528:DC%2BC3cXht1Ons7o%3D
6. H Daub K Specht A Ullrich 2004 Strategies to overcome resistance to targeted protein kinase inhibitors Nat Rev Drug Discov 3 1001 1010 15573099 10.1038/nrd1579 1:CAS:528:DC%2BD2cXhtVarsL3K (Pubitemid 39642363)
7. AM Xu PH Huang 2010 Receptor tyrosine kinase coactivation networks in cancer Cancer Res 70 3857 3860 20406984 10.1158/0008-5472.CAN-10-0163 1:CAS:528:DC%2BC3cXlvFyrt7g%3D
8. JA Engelman K Zejnullahu T Mitsudomi Y Song C Hyland JO Park N Lindeman CM Gale X Zhao J Christensen T Kosaka AJ Holmes AM Rogers F Cappuzzo T Mok C Lee BE Johnson LC Cantley PA Janne 2007 MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling Science 316 1039 1043 17463250 10.1126/science.1141478 1:CAS:528:DC%2BD2sXltlOjt7g%3D (Pubitemid 46799492)
9. R Nahta D Yu MC Hung GN Hortobagyi FJ Esteva 2006 Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer Nat Clin Pract Oncol 3 269 280 16683005 10.1038/ncponc0509 1:CAS:528: DC%2BD28Xltlagtbg%3D (Pubitemid 43731112)
10. JM Stommel AC Kimmelman H Ying R Nabioullin AH Ponugoti R Wiedemeyer AH Stegh JE Bradner KL Ligon C Brennan L Chin RA DePinho 2007 Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies Science 318 287 290 17872411 10.1126/science.1142946 1:CAS:528:DC%2BD2sXhtFCjt7vP (Pubitemid 47574858)
11. EV Cutsem Y Kang H Chung L Shen A Sawaki F Lordick J Hill M Lehle A Feyereislova Y Bang 2009 Efficacy results from the ToGA trial: a phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC) J Clin Oncol 27 18s 10.1200/JCO.2009.22.4626 Suppl. abstr LBA4509
12. T Dragovich C Campen 2009 Anti-EGFR-targeted therapy for esophageal and gastric cancers: an evolving concept J Oncol 2009 804108 19636422
13. J Iwasaki S Nihira 2009 Anti-angiogenic therapy against gastrointestinal tract cancers Jpn J Clin Oncol 39 543 551 19531544 10.1093/jjco/hyp062
14. PM Comoglio S Giordano L Trusolino 2008 Drug development of MET inhibitors: targeting oncogene addiction and expedience Nat Rev Drug Discov 7 504 516 18511928 10.1038/nrd2530 1:CAS:528:DC%2BD1cXmsVOjsb0%3D (Pubitemid 351767118)
15. HT Arkenau 2009 Gastric cancer in the era of molecularly targeted agents: current drug development strategies J Cancer Res Clin Oncol 135 855 866 19363621 10.1007/s00432-009-0583-7
16. H Grabsch S Sivakumar S Gray HE Gabbert W Muller 2010 HER2 expression in gastric cancer: rare, heterogeneous and of no prognostic value-conclusions from 924 cases of two independent series Cell Oncol 32 57 65 20208134
17. PH Huang FM White 2008 Phosphoproteomics: unraveling the signaling web Mol Cell 31 777 781 18922462 10.1016/j.molcel.2008.09.001 1:CAS:528: DC%2BD1cXht1amsb7N
18. B Macek M Mann JV Olsen 2009 Global and site-specific quantitative phosphoproteomics: principles and applications Annu Rev Pharmacol Toxicol 49 199 221 18834307 10.1146/annurev.pharmtox.011008.145606 1:CAS:528: DC%2BD1MXisV2jsLk%3D
19. F Diella CM Gould C Chica A Via TJ Gibson 2008 Phospho.ELM: a database of phosphorylation sites-update 2008 Nucleic Acids Res 36 D240 D244 17962309 10.1093/nar/gkm772 1:CAS:528:DC%2BD1cXhtVWjurw%3D (Pubitemid 351149729)
20. F Diella S Cameron C Gemund R Linding A Via B Kuster T Sicheritz-Ponten N Blom TJ Gibson 2004 Phospho.ELM: a database of experimentally verified phosphorylation sites in eukaryotic proteins BMC Bioinformatics 5 79 15212693 10.1186/1471-2105-5-79 (Pubitemid 40195424)
21. http://www.phosphosite.org
22. B Bodenmiller D Campbell B Gerrits H Lam M Jovanovic P Picotti R Schlapbach R Aebersold 2008 PhosphoPep-a database of protein phosphorylation sites in model organisms Nat Biotechnol 26 1339 1340 19060867 10.1038/nbt1208-1339 1:CAS:528:DC%2BD1cXhsVKqtr%2FO
23. F Gnad S Ren J Cox JV Olsen B Macek M Oroshi M Mann 2007 PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites Genome Biol 8 R250 18039369 10.1186/gb-2007-8-11-r250 (Pubitemid 351917499)
24. ZA Knight H Lin KM Shokat 2010 Targeting the cancer kinome through polypharmacology Nat Rev Cancer 10 130 137 20094047 10.1038/nrc2787 1:CAS:528:DC%2BC3cXps1Clug%3D%3D
25. NK Tonks 2006 Protein tyrosine phosphatases: from genes, to function, to disease Nat Rev Mol Cell Biol 7 833 846 17057753 10.1038/nrm2039 1:CAS:528:DC%2BD28XhtFSms77I (Pubitemid 44627477)
26. A Alonso J Sasin N Bottini I Friedberg A Osterman A Godzik T Hunter J Dixon T Mustelin 2004 Protein tyrosine phosphatases in the human genome Cell 117 699 711 15186772 10.1016/j.cell.2004.05.018 1:CAS:528:DC%2BD2cXltlKisbc%3D (Pubitemid 38748887)
27. VV Vintonyak AP Antonchick D Rauh H Waldmann 2009 The therapeutic potential of phosphatase inhibitors Curr Opin Chem Biol 13 272 283 19410499 10.1016/j.cbpa.2009.03.021 1:CAS:528:DC%2BD1MXosVWlur4%3D
28. CS Gan T Guo H Zhang SK Lim SK Sze 2008 A comparative study of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) versus SCX-IMAC-based methods for phosphopeptide isolation/enrichment J Proteome Res 7 4869 4877 18828627 10.1021/pr800473j 1:CAS:528:DC%2BD1cXhtF2ju7nM
29. T Guo CS Gan H Zhang Y Zhu OL Kon SK Sze 2008 Hybridization of pulsed-Q dissociation and collision-activated dissociation in linear ion trap mass spectrometer for iTRAQ quantitation J Proteome Res 7 4831 4840 18837533 10.1021/pr800403z 1:CAS:528:DC%2BD1cXht1Smtr3E
30. Y Zhu T Guo JE Park X Li W Meng A Datta M Bern SK Lim SK Sze 2009 Elucidating in vivo structural dynamics in integral membrane protein by hydroxyl radical footprinting Mol Cell Proteomics 8 1999 2010 19473960 10.1074/mcp.M900081-MCP200 1:CAS:528:DC%2BD1MXhtVSjtbnM
31. D Fenyo RC Beavis 2003 A method for assessing the statistical significance of mass spectrometry-based protein identifications using general scoring schemes Anal Chem 75 768 774 12622365 10.1021/ac0258709 (Pubitemid 36232428)
32. LY Geer SP Markey JA Kowalak L Wagner M Xu DM Maynard X Yang W Shi SH Bryant 2004 Open mass spectrometry search algorithm J Proteome Res 3 958 964 15473683 10.1021/pr0499491 1:CAS:528:DC%2BD2cXltl2lur8%3D (Pubitemid 39425651)
33. JC Obenauer LC Cantley MB Yaffe 2003 Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs Nucleic Acids Res 31 3635 3641 12824383 10.1093/nar/gkg584 1:CAS:528: DC%2BD3sXltVWju74%3D (Pubitemid 37442212)
34. B Bodenmiller LN Mueller M Mueller B Domon R Aebersold 2007 Reproducible isolation of distinct, overlapping segments of the phosphoproteome Nat Methods 4 231 237 17293869 10.1038/nmeth1005 1:CAS:528:DC%2BD2sXitFChsbs%3D (Pubitemid 46358873)
35. AJ Alpert 2008 Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides Anal Chem 80 62 76 18027909 10.1021/ac070997p 1:CAS:528:DC%2BD2sXhtlaktLbK (Pubitemid 351448406)
36. G Alves WW Wu G Wang RF Shen YK Yu 2008 Enhancing peptide identification confidence by combining search methods J Proteome Res 7 3102 3113 18558733 10.1021/pr700798h 1:CAS:528:DC%2BD1cXnt1ymsb4%3D
37. H Zhang T Guo X Li A Datta JE Park J Yang SK Lim JP Tam SK Sze 2010 Simultaneous characterization of glyco- and phospho-proteomes of mouse brain membrane proteome with electrostatic repulsion hydrophilic interaction chromatography (ERLIC) Mol Cell Proteomics 9 635 647 20047950 10.1074/mcp.M900314-MCP200 1:CAS:528:DC%2BC3cXlvFCjtbY%3D
38. B Sarg W Helliger H Talasz B Forg HH Lindner 2006 Histone H1 phosphorylation occurs site-specifically during interphase and mitosis: identification of a novel phosphorylation site on histone H1 J Biol Chem 281 6573 6580 16377619 10.1074/jbc.M508957200 1:CAS:528:DC%2BD28XhvFOgs7Y%3D (Pubitemid 43847591)
39. SA Beausoleil J Villen SA Gerber J Rush SP Gygi 2006 A probability-based approach for high-throughput protein phosphorylation analysis and site localization Nat Biotechnol 24 1285 1292 16964243 10.1038/nbt1240 1:CAS:528:DC%2BD28XhtVGgsrjF (Pubitemid 44564776)
40. D Schwartz SP Gygi 2005 An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets Nat Biotechnol 23 1391 1398 16273072 10.1038/nbt1146 1:CAS:528:DC%2BD2MXhtFyis7vI (Pubitemid 41679391)
41. R Amanchy B Periaswamy S Mathivanan R Reddy SG Tattikota A Pandey 2007 A curated compendium of phosphorylation motifs Nat Biotechnol 25 285 286 17344875 10.1038/nbt0307-285 1:CAS:528:DC%2BD2sXisFynsro%3D (Pubitemid 46398759)
42. DP Slaughter HW Southwick W Smejkal 1953 Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 963 968 13094644 10.1002/1097-0142(195309)6:5<963::AID- CNCR2820060515>3.0.CO;2-Q 1:STN:280:DyaG2c%2FhsFCntw%3D%3D
43. H Subramanian HK Roy P Pradhan MJ Goldberg J Muldoon RE Brand C Sturgis T Hensing D Ray A Bogojevic J Mohammed JS Chang V Backman 2009 Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy Cancer Res 69 5357 5363 19549915 10.1158/0008-5472.CAN-08-3895 1:CAS:528: DC%2BD1MXnvFWqu7g%3D
44. H Kuniyasu W Yasui H Yokozaki Y Kitadai E Tahara 1993 Aberrant expression of c-met mRNA in human gastric carcinomas Int J Cancer 55 72 75 8344755 10.1002/ijc.2910550114 1:CAS:528:DyaK2cXhs1ShsbY%3D (Pubitemid 23261709)
45. DA Heideman PJ Snijders E Bloemena CJ Meijer GJ Offerhaus SG Meuwissen WR Gerritsen ME Craanen 2001 Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma J Pathol 194 428 435 11523050 10.1002/path.934 1:CAS:528:DC%2BD3MXmslWku7k%3D (Pubitemid 32782667)
46. GA Smolen R Sordella B Muir G Mohapatra A Barmettler H Archibald WJ Kim RA Okimoto DW Bell DC Sgroi JG Christensen J Settleman DA Haber 2006 Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752 Proc Natl Acad Sci USA 103 2316 2321 16461907 10.1073/pnas.0508776103 1:CAS:528:DC%2BD28XhslGjtrg%3D (Pubitemid 43271667)
47. RI Nicholson JM Gee ME Harper 2001 EGFR and cancer prognosis Eur J Cancer 37 Suppl 4 S9 S15 11597399 10.1016/S0959-8049(01)00231-3 1:CAS:528: DC%2BD3MXntlOku7w%3D
48. SY Kanta T Yamane Y Dobashi F Mitsui K Kono A Ooi 2006 Topoisomerase II alpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study Hum Pathol 37 1333 1343 16949920 10.1016/j.humpath.2006.05. 008 1:CAS:528:DC%2BD28XpvV2ls70%3D (Pubitemid 44380283)
49. N Tokuyasu K Shomori K Nishihara H Kawaguchi S Fujioka K Yamaga M Ikeguchi H Ito 2008 Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance Gastric Cancer 11 37 46 18373176 10.1007/s10120-008-0451-1 1:CAS:528: DC%2BD1cXjvFKlurc%3D (Pubitemid 351464483)
50. W Yuan Z Chen S Wu J Ge S Chang X Wang J Chen 2009 Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis Pathol Oncol Res 15 473 478 19048396 10.1007/s12253-008-9132-y 1:CAS:528:DC%2BD1MXhsFCltrbO
51. YN Zhou CP Xu B Han M Li L Qiao DC Fang JM Yang 2002 Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival World J Gastroenterol 8 987 993 12439911 1:CAS:528:DC%2BD38XpvVSgtbk%3D (Pubitemid 35446407)
52. S Yamamoto Y Tomita Y Hoshida S Takiguchi Y Fujiwara T Yasuda Y Doki K Yoshida K Aozasa H Nakamura M Monden 2006 Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma Clin Cancer Res 12 117 122 16397032 10.1158/1078-0432.CCR-05-1347 1:CAS:528:DC%2BD28Xht1Gmtg%3D%3D (Pubitemid 43166184)
53. M Nikolova M Guenova H Taskov E Dimitrova M Staneva 1998 Levels of expression of CAF7 (CD98) have prognostic significance in adult acute leukemia Leuk Res 22 39 47 9585078 10.1016/S0145-2126(97)00129-X 1:CAS:528: DyaK1cXislalsr4%3D (Pubitemid 28167544)
54. S Esseghir JS Reis-Filho A Kennedy M James MJ O'Hare R Jeffery R Poulsom CM Isacke 2006 Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts J Pathol 210 420 430 17054309 10.1002/path.2071 1:CAS:528:DC%2BD28XhtlGhs7%2FK (Pubitemid 44830602)
55. K Kaira N Oriuchi H Imai K Shimizu N Yanagitani N Sunaga T Hisada T Ishizuka Y Kanai H Endou T Nakajima M Mori 2009 Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung Cancer Sci 100 249 254 10.1111/j.1349-7006.2008.01029.x 1:CAS:528:DC%2BD1MXhvVyls74%3D
56. GW Prager M Poettler M Schmidinger PR Mazal M Susani CC Zielinski A Haitel 2009 CD98hc (SLC3A2), a novel marker in renal cell cancer Eur J Clin Invest 39 304 310 19292886 10.1111/j.1365-2362.2009.02096.x 1:CAS:528: DC%2BD1MXkvVWrsbs%3D
57. SP Jackson J Bartek 2009 The DNA-damage response in human biology and disease Nature 461 1071 1078 19847258 10.1038/nature08467 1:CAS:528: DC%2BD1MXhtlGktLrK
58. JW Harper SJ Elledge 2007 The DNA damage response: 10 years after Mol Cell 28 739 745 18082599 10.1016/j.molcel.2007.11.015 1:CAS:528: DC%2BD1cXktVWisQ%3D%3D (Pubitemid 350217064)
59. G Manning DB Whyte R Martinez T Hunter S Sudarsanam 2002 The protein kinase complement of the human genome Science 298 1912 1934 12471243 10.1126/science.1075762 1:CAS:528:DC%2BD38Xpt1Wisb0%3D (Pubitemid 35425239)
60. M Thomson 2002 Evidence of undiscovered cell regulatory mechanisms: phosphoproteins and protein kinases in mitochondria Cell Mol Life Sci 59 213 219 11915939 10.1007/s00018-002-8417-7 1:CAS:528:DC%2BD38XhvFKmsbk%3D (Pubitemid 34169509)
61. C Horbinski CT Chu 2005 Kinase signaling cascades in the mitochondrion: a matter of life or death Free Radic Biol Med 38 2 11 15589366 10.1016/j.freeradbiomed.2004.09.030 1:CAS:528:DC%2BD2cXhtVKrt7fJ (Pubitemid 39626903)
62. Deng N, Zhang J, Zong C, Wang Y, Lu H, Yang P, Wang W, Young GW, Korge P, Lotz C, Doran P, Liem DA, Apweiler R, Weiss JN, Duan H, Ping P (2010) Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics (In press) (doi: 10.1074/mcp.M110.000117 )
63. WJ Deng S Nie J Dai JR Wu R Zeng 2010 Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages Mol Cell Proteomics 9 100 116 19700791 10.1074/mcp.M900020-MCP200 1:CAS:528:DC%2BC3cXjtFWhs78%3D
64. Z Cui J Hou X Chen J Li Z Xie P Xue T Cai P Wu T Xu F Yang 2010 The profile of mitochondrial proteins and their phosphorylation signaling network in INS-1 beta cells J Proteome Res 9 2898 2908 20380455 10.1021/pr100139z 1:CAS:528:DC%2BC3cXltVylt7o%3D
65. J Reinders K Wagner RP Zahedi D Stojanovski B Eyrich M van der Laan P Rehling A Sickmann N Pfanner C Meisinger 2007 Profiling phosphoproteins of yeast mitochondria reveals a role of phosphorylation in assembly of the ATP synthase Mol Cell Proteomics 6 1896 1906 17761666 10.1074/mcp.M700098-MCP200 1:CAS:528:DC%2BD2sXhsVeisbrF (Pubitemid 350201867)
66. J Ito NL Taylor I Castleden W Weckwerth AH Millar JL Heazlewood 2009 A survey of the Arabidopsis thaliana mitochondrial phosphoproteome Proteomics 9 4229 4240 19688752 10.1002/pmic.200900064 1:CAS:528:DC%2BD1MXhtV2jt7nO